Skip to main content
  1. Courses
  2. Out with the Old and In wit...

Out with the Old and In with the New: An Updated Approach to the Cytologic Classification of Tumors



Original release date: February 13, 2023
Access to this course expires on:  January 11, 2026 at 11:59 PM Pacific Time
CME 12.5

Course Description
Multiple revisions and updates have recently been created for standardization of the cytologic classification of non-neoplastic and neoplastic processes in the pancreatobiliary tract, liver, thyroid, head and neck (including salivary gland), urine, kidneys, adrenal gland, lung and soft tissue. These standardized reporting schemes provide a framework for consistent categorization of cytopathology reports. They allow cytopathologists to convey clear, consistent diagnostic information, in language uniformly understood by pathologists and clinicians the world over. New developments in the diagnosis, grading and staging are not fully appreciated in the community, often leading to errors in diagnosis and impaired management. This case-based course will illustrate daily challenges, new guidelines, and practical clues to the proper handling of specimens from these sites along with accurate cytologic diagnosis of neoplasms in, and their distinction from, key cytomorphologic mimics. This will offer pathologists a unique perspective into the diagnostic morphometric signatures of key entities, which they can apply to daily practice even in the smaller hospital or private practice setting.

Target Audience
Cytopathologists, general surgical pathologists who sign out cytopathology specimens, cytopathologists with special interest in pathology from these sites, and pathologists-in-training (residents and fellows).

Learning Objectives
Upon completion of this educational activity, learners will be able to:
  • Learn new concepts and terminological guidelines in the cytologic classification of neoplasms from multiple sites
  • Learn when and how to integrate clinical findings and ancillary tests in precise cytologic diagnosis
  • Recognize the limitations and pitfalls in using/interpreting ancillary studies for cytologic diagnosis of neoplasms in multiple sites
  • Use an algorithmic approach to the differential diagnosis for neoplasms at multiple sites

Continuing Medical Education
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 12.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any financial relationship(s) that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and mitigated all identified conflicts of interest, as applicable.

The following faculty and IM Coordinator reported no relevant financial relationships: Michelle Reid, MD, MSc, Adebowale Adeniran, MD, Liron Pantanowitz, MD, MHA, William Faquin, MD, PhD

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME credit, all learners must complete the evaluation. Learners can now self-submit CME on all earned certificates. View and print your certificates by clicking here.

USCAP members receive a discount on all e-Learning courses. Not A Member? Click Here to sign up today.